WikiFX

Sagot

Based on my research and personal due diligence, I was unable to find reliable, transparent details about the specific trading costs for index products like the US100 when using Credicorp Capital. This lack of transparency is, in my experience, a significant red flag. According to public records, this broker currently holds no valid regulatory licenses and has been flagged for a suspicious regulatory status and a very low trust score. From my perspective, not being able to verify fundamental information—such as the spread, commission, swap fees, or even the underlying trading conditions for widely traded indices—creates substantial uncertainty. As a trader who considers cost analysis an essential part of risk management, I strongly prefer brokers who clearly publish all fee structures before account opening. In the case of Credicorp Capital, the absence of regulatory oversight and lack of clear, accessible information about their total trading cost for index products like US100 makes it impossible for me to accurately evaluate their cost competitiveness. Until the situation changes and they become more transparent and properly regulated, I would personally avoid executing trades—especially in volatile instruments—without fully understanding all associated costs up front. For me, cost clarity is simply non-negotiable in my broker selection process.